New Nanoparticles Shrink Tumors in Mice

A team of researchers from the MIT-Harvard CCNE has developed RNA-delivering nanoparticles that allow for rapid screening of new gene targets in mice. This could relieve a significant bottleneck in cancer-drug development, and help identify new targets for cancer drugs.

Read the MIT News story.

Read more Alliance in the News.

Lessons Learned in Creating Biomedical Nanoparticles for Human Use

Gold Nanorods Hitch Ride on Immune Cells that Target Breast Tumors

Polymer Nanoparticle Overcomes Anticancer Drug Resistance

Gold Nanoparticles Could Treat Prostate Cancer with Fewer Side Effects than Chemotherapy

Nanoparticle Enhances Anticancer Immune Therapy with a One-Two Punch

Enter your email below to receive news and updates:

	Watch a Video Journey Into the World of Nanotechnology in Cancer
	Discover how nanotechnology works and what it is. See animations of Nanowires, Cantilevers, and Nanoshells.
	View our Image Library to see science at the nanoscale
	Read Alliance in the News to learn about recent advances in cancer nanotechnology

Nanotechnology allows researchers to study cancer in its earliest stages of progression, enabling early detection and development of novel therapies to target the disease. Learn more about nanotechnology's impact on cancer

Learn more about potential uses for nanotechnology for diagnosing and treating cancer. Listen to the podcast series